CONMED Corp — Director's Dealing 2021

Aug 30, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2021-08-27

Reporting Person: KENNEDY JOHN JED (Group Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-27	Common Stock	M	4940	$39.87	Acquired	12315	Direct
2021-08-27	Common Stock	S	4940	$134.7768	Disposed	7375	Direct
2021-08-27	Common Stock	M	498	$41.93	Acquired	7873	Direct
2021-08-27	Common Stock	S	498	$134.75	Disposed	7375	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-27	Options To Purchase Common Stock	$39.87	M	4940	Disposed	2026-03-01	Common Stock (4940)	Direct
2021-08-27	Options To Purchase Common Stock	$41.93	M	498	Disposed	2027-03-01	Common Stock (498)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.75 to $135.05. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F2: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.